PRPO logo.png
New York State Approves Precipio’s HemeScreen for POL clinical use
November 18, 2021 10:00 ET | Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
researchdrivelogo.jpg
Global Bloodstream Infection Testing Market Anticipated to Surpass $7,722.2 Million, Rising at 8.4% CAGR from 2019 to 2027 – Exclusive Report [247 Pages] By Research Dive
October 20, 2021 09:10 ET | Research Dive
New York, USA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- A new report on the global bloodstream infection testing market has been added by Research Dive to its repository. According to the report, the...
PRPO logo.png
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
August 26, 2021 10:00 ET | Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
researchdrivelogo.jpg
Increasing Cases of Coronavirus Infection around the World to Propel the Growth of Global COVID-19 Diagnostics Market – Exclusive Report [410 Pages] By Research Dive
August 18, 2021 09:04 ET | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global covid-19 diagnostics market is expected to generate a revenue of $65,750.1 million by...
researchdrivelogo.jpg
Rising Demand for Animal Testing Alternatives for Drug Testing to Boost the Growth of the Global Organ on Chip Market by 2028 – Exclusive Report [180 Pages] By Research Dive
August 18, 2021 09:02 ET | Research Dive
New York, USA, Aug. 18, 2021 (GLOBE NEWSWIRE) -- As per a latest report published by Research Dive, the global organ on chip market is estimated to register a revenue of $697,654.3 thousand by 2028,...
researchdrivelogo.jpg
Rising Sepsis Cases Along with the Growing Prevalence of Infectious Disorders Expected to Surge the Growth of the Bloodstream Infection Testing Market by 2027 – Exclusive Report [247 Pages] By Research Dive
June 23, 2021 09:05 ET | Research Dive
New York, USA, June 23, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global bloodstream infection testing market is projected to register a revenue of $7,722.2...
ScipherTM.png
Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test
June 15, 2021 08:00 ET | Scipher Medicine Corporation
Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohort PrismRA demonstrates a more...
PRPO logo.png
Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time
May 10, 2021 10:30 ET | Precipio, Inc.
NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
PRPO logo.png
Mr. Ron Andrews joins Precipio’s Board of Directors
March 03, 2021 13:00 ET | Precipio, Inc.
NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company’s Board of Directors. As...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Receives Licensure From the State of California for Clinical Testing Laboratory (CLIA) Allowing for Clinical Sample Testing
December 08, 2020 20:06 ET | Sorrento Therapeutics, Inc.
Sorrento receives Clinical Laboratory Improvement Amendments (CLIA) license from the State of California for clinical sample testingSorrento intends to initially offer three diagnostic tests for...